Zoloft Birth Defect Risks Extend Beyond PPHN
Zoloft (sertraline) is infamous for its PPHN risks. As the FDA has previously warned, women who took antidepressants like Zoloft – a class of drugs collectively known as selective serotonin reuptake inhibitors (SSRIs) – after the 20th week of pregnancy were six times more likely to give birth to children who suffer from persistent pulmonary hypertension (PPHN), a life-threatening lung condition.
Although concern about PPHN is well placed, some Zoloft patients have lost sight of the bigger picture: the birth defect risks associated with Zoloft extend well beyond PPHN. Sertraline, the agent in Zoloft, is a dangerous drug. During pregnancy, it passes through the mother’s umbilical cord, exposing the developing fetus to as much as one-third of the Zoloft dosage that the mother consumes. Consequently, first trimester use of Zoloft has been shown to substantially increase the risk of such birth defects as omphalocele, anal atresia, limb reduction defects, and septal defects.
Has your child been injured as a result of dangerous drugs like Zoloft and other SSRIs. Fears Nachawati protects consumers and victims just like you. Find out how our class action lawsuit might help you by contacting us. We’re ready to help you! For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com.
